STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
argenx (Nasdaq: ARGX), a global immunology company focused on severe autoimmune diseases, announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. Karl Gubitz, the company's Chief Financial Officer, will engage in a fireside chat on Tuesday, June 10, 2025, at 8:40 AM ET in Miami, FL. The presentation will be accessible via live webcast through the Investors section of argenx's website at argenx.com/investors, with a replay available for approximately 30 days following the event.
Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

June 3, 2025

Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karl Gubitz, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025 at 8:40 AM ET in Miami, FL.

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedInInstagramFacebook, and YouTube.

Contacts

Media:

Ben Petok
bpetok@argenx.com

Investors:

Alexandra Roy
aroy@argenx.com


FAQ

When is argenx (ARGX) presenting at the Goldman Sachs Healthcare Conference 2025?

argenx will present at the Goldman Sachs Healthcare Conference on Tuesday, June 10, 2025 at 8:40 AM ET in Miami, FL.

Who will represent argenx (ARGX) at the Goldman Sachs Healthcare Conference 2025?

Karl Gubitz, Chief Financial Officer of argenx, will participate in a fireside chat at the conference.

How can I watch argenx's (ARGX) presentation at the Goldman Sachs Healthcare Conference?

The presentation can be accessed via live webcast through the Investors section of argenx's website at argenx.com/investors.

How long will argenx's (ARGX) Goldman Sachs Conference presentation replay be available?

A replay of the webcast will be available on the argenx website for approximately 30 days following the presentation.
Argenx Se

NASDAQ:ARGX

ARGX Rankings

ARGX Latest News

ARGX Latest SEC Filings

ARGX Stock Data

56.75B
60.98M
0%
53.36%
2.94%
Biotechnology
Healthcare
Link
Netherlands
Amsterdam